Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Nippon Shinyaku

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Nippon Shinyaku's Japan sales performance.

nippon

Biosimilar Remicade reaches market in Japan and India

Biosimilar Remicade reaches market in Japan and India

Biosimilar Remicade reaches market in Japan and India. Nippon Kayaku’ s version of arthritis drug was approved in July. ... In Japan, Nippon Kayaku has launched a biosimilar version of Remicade (infliximab) originally developed by South Korean

Deal Watch table for September 2013

Deal Watch table for September 2013 50. 5. Shin Nippon Biomedical / Transcept Pharma. Licence. TO-2070 nasal powder for acute migraine.

First biosimilar mAb gets the nod in EU

First biosimilar mAb gets the nod in EU In Japan the drug will be co-marketed by Celltrion's development partner Nippon Kayaku.

New formulations of Pralia and Enbrel head list of new drugs in Japan

New formulations of Pralia and Enbrel head list of new drugs in Japan The established version of the drug contained 40mg telmisartan and the same dose of amlodipine, and the line extension - which like its predecessor will be co-promoted by Nippon Boehringer Ingelheim -

Result pages: 1 | 2 | 3 | 4 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics